Skip to main content
# Title Department Research Year
81 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
82 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
83 Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
84 Ratiometric fluorometric determination of sulfide using graphene quantum dots and self‑assembled thiolate‑capped gold nanoclusters triggered by aluminum Department of Pharmaceutical Analytical Chemistry 2023
85 Fully functional monocytic MDSC generation from the murine HoxB8 cell line 2023
86 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
87 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
88 Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe† Department of Pharmaceutical Analytical Chemistry 2023
89 A feasible HPTLC method for concurrent quantitation of allopurinol-montelukast co-therapy in plasma and evaluation of their hepatic and renal effects in rats: Analytical, biochemical, and histopathological study Department of Pharmaceutical Analytical Chemistry 2023
90 Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings Department of Pharmaceutics 2023